Ripple Effects of the FDA’s Stance on CBD Products: Q&A With Attorney Robert Hoban
By John Schroyer When the U.S. Food and Drug Administration stepped in – again – to warn CBD…
News February 24By John Schroyer When the U.S. Food and Drug Administration stepped in – again – to warn CBD…
News February 24A year ago, the U.S. Food and Drug Administration warned six companies to stop making claims about the…
News February 11The U.S. Food and Drug Administration has ruled that cannabidiol products don’t fit under the legal definition of…
News May 15In late February, the U.S. Food and Drug Administration sent stern letters to six companies peddling CBD products…
News March 10